About Company
- Legal Name: Inabata France
- International Name: INABATA France S.A.S., Issy-les-Moulineaux, France
- Brand / Trade Name: Inabata
- Registered country: France
- Address: 6-8, Rue du 4 Septembre, Immeuble Le Rubix, Issy-Les-Moulineaux, Wissous • Île-de-France
- Number of employees: 25 - 49
Description:
With more than 40 years of history in API manufacturing, Pharmasynthese belongs to the Japanese Inabata Group through its French subsidiary Inabata France, offering GMP manufacturing and distribution of active pharmaceutical ingredients, advanced intermediates and specialty products.
Business Activities
Cosmetics & Personal Care
Supplier
Pharma Chemicals
DistributorManufacturerAPI Manufacturer
Contract & Outsourcing Services
ManufacturerAPI Manufacturer
ATC (Anatomical Therapeutic Chemical) Classification
ManufacturerAPI Manufacturer
Innovator APIs
ManufacturerAPI Manufacturer
Active Pharmaceutical Ingredients (APIs)
API ManufacturerManufacturer
Sales Markets
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
Key Products/Services
- Active Pharmaceutical Ingredients (APIs): Active Pharmaceutical Ingredients, AMOROLFINE HCl
- Cosmetics & Personal Care: Nutrition and personal care ingredients
- Pharma Chemicals: 2 Phenyl Acrylamide, API & INTERMEDIATES, Specialty chemical distribution
- ATC (Anatomical Therapeutic Chemical) Classification: SERTACONAZOLE NITRATE
- Innovator APIs: FENTICONAZOLE NITRATE
Our Products & Services
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment